OPA1 and diabetes mellitus: Research has indicated that OPA1-mediated mitochondrial fusion exerts both regulatory and protective effects against liver and myocardial damage induced by diabetes, primarily through the PKG-STAT3 pathway (Wang et al., 2022; Chang et al., 2023).